Update of FDA's critical path initiative

Samir Khleif

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)173-174
Number of pages2
JournalClinical Advances in Hematology and Oncology
Volume7
Issue number3
StatePublished - Jun 9 2009

Fingerprint

Critical Pathways
Clinical Pharmacology
Drug Industry
United States Food and Drug Administration
Tumor Biomarkers
Biomedical Research

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Update of FDA's critical path initiative. / Khleif, Samir.

In: Clinical Advances in Hematology and Oncology, Vol. 7, No. 3, 09.06.2009, p. 173-174.

Research output: Contribution to journalArticle

Khleif, Samir. / Update of FDA's critical path initiative. In: Clinical Advances in Hematology and Oncology. 2009 ; Vol. 7, No. 3. pp. 173-174.
@article{ade043cae44045219dd8fb0c8b47119c,
title = "Update of FDA's critical path initiative",
author = "Samir Khleif",
year = "2009",
month = "6",
day = "9",
language = "English (US)",
volume = "7",
pages = "173--174",
journal = "Clinical Advances in Hematology and Oncology",
issn = "1543-0790",
publisher = "Millennium Medical Publishing, Inc.",
number = "3",

}

TY - JOUR

T1 - Update of FDA's critical path initiative

AU - Khleif, Samir

PY - 2009/6/9

Y1 - 2009/6/9

UR - http://www.scopus.com/inward/record.url?scp=66349102918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66349102918&partnerID=8YFLogxK

M3 - Article

C2 - 19398939

AN - SCOPUS:66349102918

VL - 7

SP - 173

EP - 174

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

SN - 1543-0790

IS - 3

ER -